CGC
Canopy Growth Corp
NASDAQ: CGC · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$1.11
+1.83% today
Updated 2026-04-30
Market cap
$619.73M
P/E ratio
—
P/S ratio
2.23x
EPS (TTM)
$-1.36
Dividend yield
—
52W range
$1 – $2
Volume
11.0M
WallStSmart proprietary scores
25
out of 100
Grade: F
Strong Sell
Investment rating
2.7
Growth
F5.0
Quality
C+2.0
Profitability
F5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$1.80
+61.80%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy1 Buy5 Hold0 Sell1 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at -117.30%
- Negative free cash flow $-19.13M
- Revenue declining -0.30% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $475.70M | $333.25M | $297.15M | $269.00M | $278.39M |
| Net income | $-310.04M | $-3.28B | $-657.27M | $-598.12M | $-62.63M |
| EPS | — | — | — | — | $-1.36 |
| Free cash flow | $-593.92M | $-568.00M | $-285.95M | $-177.03M | $-19.13M |
| Profit margin | -65.18% | -983.68% | -221.19% | -222.35% | -117.30% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-31 | YANOFSKY, THERESA | Sale | 10,373 | $0.93 |
| 2026-03-31 | LAZZARATO, DAVID ANGELO | Sale | 15,624 | $0.93 |
| 2026-03-31 | BAYERN, JOSEPH | Sale | 2,658 | $0.93 |
Peer comparison
Smart narrative
Canopy Growth Corp trades at $1.11. Our Smart Value Score of 25/100 indicates the stock is weak. TTM revenue stands at $278.39M. with profit margins at -117.30%.
Frequently asked questions
What is Canopy Growth Corp's stock price?
Canopy Growth Corp (CGC) trades at $1.11.
Is Canopy Growth Corp overvalued?
Smart Value Score 25/100 (Grade F, Strong Sell).
What is the price target of Canopy Growth Corp (CGC)?
The analyst target price is $1.80, representing +61.8% upside from the current price of $1.11.
What is Canopy Growth Corp's revenue?
TTM revenue is $278.39M.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio2.23x
ROE-48.50%
Beta2.32
50D MA$1.07
200D MA$1.22
Shares out0.42B
Float0.38B
Short ratio—
Avg volume11.0M
Performance
1 week-13.04%
1 month+40.07%
3 months+5.26%
YTD+5.26%
1 year—
3 years—
5 years—